Literature DB >> 18323782

Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma.

Jeffrey P North1, Toshiro Kageshita, Daniel Pinkel, Philip E LeBoit, Boris C Bastian.   

Abstract

Primary melanoma can recur at the excision site if not excised with a safety margin of surrounding uninvolved skin. To characterize the nature of residual melanoma in the skin surrounding primary tumors targeted by safety margins, we used array comparative genomic hybridization and fluorescent in situ hybridization to detect and spatially map aberrations in the skin adjacent to acral melanomas. Melanocytic cells with genetic amplifications in histopathologically normal skin (field cells) were detected exclusively in the epidermis in 84% of 19 cases, with a mean extension of 6.1 mm (in situ melanomas) and 4.5 mm (invasive melanomas) beyond the histopathological margin. Genetic profiling of these field cells indicated that they represent an early phase of disease preceding melanoma in situ. The extent of field cells did not correlate with tumor depth or diameter, indicating that tumor depth is not suited to predict the extent of field cells. These results demonstrate that, on acral sites, melanoma field cells extend significantly into seemingly normal skin. These field cells provide a plausible explanation for the tendency of certain melanoma types to recur locally despite apparently having undergone complete excision.

Entities:  

Mesh:

Year:  2008        PMID: 18323782      PMCID: PMC2825251          DOI: 10.1038/jid.2008.41

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  14 in total

1.  Locally recurrent malignant melanoma characteristics and outcomes: a single-institution study.

Authors:  J K Wildemore; L Schuchter; R Mick; M Synnestvedt; R Elenitsas; I Bedrosian; B J Czerniecki; D Guerry; S R Lessin; D E Elder; L P Bucky
Journal:  Ann Plast Surg       Date:  2001-05       Impact factor: 1.539

2.  Distinct sets of genetic alterations in melanoma.

Authors:  John A Curtin; Jane Fridlyand; Toshiro Kageshita; Hetal N Patel; Klaus J Busam; Heinz Kutzner; Kwang-Hyun Cho; Setsuya Aiba; Eva-Bettina Bröcker; Philip E LeBoit; Dan Pinkel; Boris C Bastian
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

3.  Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization.

Authors:  B C Bastian; P E LeBoit; H Hamm; E B Bröcker; D Pinkel
Journal:  Cancer Res       Date:  1998-05-15       Impact factor: 12.701

4.  Cyclin D1 is a candidate oncogene in cutaneous melanoma.

Authors:  Edward R Sauter; Un-Cheol Yeo; Andrea von Stemm; Weizhu Zhu; Samuel Litwin; David S Tichansky; Giuseppa Pistritto; Mark Nesbit; Dan Pinkel; Meenhard Herlyn; Boris C Bastian
Journal:  Cancer Res       Date:  2002-06-01       Impact factor: 12.701

5.  Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features.

Authors:  B C Bastian; P E LeBoit; D Pinkel
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

6.  Analysis of prognosis and disease progression after local recurrence of melanoma.

Authors:  X D Dong; D Tyler; J L Johnson; P DeMatos; H F Seigler
Journal:  Cancer       Date:  2000-03-01       Impact factor: 6.860

7.  Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin.

Authors:  B C Bastian; M Kashani-Sabet; H Hamm; T Godfrey; D H Moore; E B Bröcker; P E LeBoit; D Pinkel
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

8.  Classifying melanocytic tumors based on DNA copy number changes.

Authors:  Boris C Bastian; Adam B Olshen; Philip E LeBoit; Daniel Pinkel
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

9.  The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma.

Authors:  J W Kelly; R W Sagebiel; W Calderon; L Murillo; R L Dakin; M S Blois
Journal:  Ann Surg       Date:  1984-12       Impact factor: 12.969

10.  Relationship between disease-free interval and survival in patients with recurrent melanoma.

Authors:  N J Crowley; H F Seigler
Journal:  Arch Surg       Date:  1992-11
View more
  15 in total

1.  The correlation of TRPM1 (Melastatin) mRNA expression with microphthalmia-associated transcription factor (MITF) and other melanogenesis-related proteins in normal and pathological skin, hair follicles and melanocytic nevi.

Authors:  Song Lu; Andrzej Slominski; Sung-Eun Yang; Christine Sheehan; Jeffrey Ross; J Andrew Carlson
Journal:  J Cutan Pathol       Date:  2010-04       Impact factor: 1.587

Review 2.  Malignant melanoma of sun-protected sites: a review of clinical, histological, and molecular features.

Authors:  Emily A Merkel; Pedram Gerami
Journal:  Lab Invest       Date:  2017-01-16       Impact factor: 5.662

Review 3.  The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin.

Authors:  David C Whiteman; William J Pavan; Boris C Bastian
Journal:  Pigment Cell Melanoma Res       Date:  2011-08-16       Impact factor: 4.693

Review 4.  Translational pathology, genomics and the development of systemic therapies for acral melanoma.

Authors:  Yian Ann Chen; Jamie K Teer; Zeynep Eroglu; Jheng-Yu Wu; John M Koomen; Florian A Karreth; Jane L Messina; Keiran S M Smalley
Journal:  Semin Cancer Biol       Date:  2019-11-02       Impact factor: 15.707

Review 5.  [Diseases of the nails].

Authors:  E Haneke
Journal:  Hautarzt       Date:  2013-07       Impact factor: 0.751

6.  Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma.

Authors:  Scott R Dalton; Pedram Gerami; Nicholas A Kolaitis; Susan Charzan; Rob Werling; Philip E LeBoit; Boris C Bastian
Journal:  Am J Surg Pathol       Date:  2010-02       Impact factor: 6.394

Review 7.  The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia.

Authors:  Boris C Bastian
Journal:  Annu Rev Pathol       Date:  2014       Impact factor: 23.472

8.  The role of CCND1 alterations during the progression of cutaneous malignant melanoma.

Authors:  Laura Vízkeleti; Szilvia Ecsedi; Zsuzsa Rákosy; Adrienn Orosz; Viktória Lázár; Gabriella Emri; Viktória Koroknai; Tímea Kiss; Róza Ádány; Margit Balázs
Journal:  Tumour Biol       Date:  2012-09-23

9.  KIT as a therapeutic target in melanoma.

Authors:  Maria C Garrido; Boris C Bastian
Journal:  J Invest Dermatol       Date:  2010-01       Impact factor: 8.551

10.  Current concepts of metastasis in melanoma.

Authors:  Blazej Zbytek; J Andrew Carlson; Jacqueline Granese; Jeffrey Ross; Martin C Mihm; Andrzej Slominski
Journal:  Expert Rev Dermatol       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.